Article
ADAM17 Deletion Protects Against Type1 Diabetes-Associated Kidney Injury by Modulating Inflammatory and Fibrotic Pathways
2026-02-08
Abstract excerpt
0 <h4>Background</h4> A Disintegrin and Metalloprotease 17 (ADAM17) is a key sheddase regulating multiple inflammatory and growth factor–related pathways implicated in diabetic kidney disease (DKD). While cell-specific deletion of ADAM17 has shown renoprotective effects, the impact of global ADAM17 ablation in the context of diabetes remains incompletely understood. <h4>Methods</h4> We investigated the effects o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2dce794e-7b34-5758-a9ae-5da4132a7e9a
- DOI
- 10.64898/2026.02.05.704041
